These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23258422)

  • 1. Donepezil abolishes anticholinergic activity in a patient with amnesia.
    Konishi K; Hori K; Tomioka H; Minegishi G; Tani M; Tanaka H; Akita R; Yokoyama S; Oshio T; Hachisu M
    Pharmacology; 2013; 91(1-2):86-91. PubMed ID: 23258422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    Devanand DP; Lentz C; Chunga RE; Ciarleglio A; Scodes JM; Andrews H; Schofield PW; Stern Y; Huey ED; Bell K; Pelton GH
    J Alzheimers Dis; 2017; 60(4):1525-1531. PubMed ID: 29081417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 4. Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility.
    Tariot PN; Jakimovich L
    J Am Med Dir Assoc; 2003; 4(4):216-9. PubMed ID: 12837144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Psychopharmacology (Berl); 2016 Apr; 233(7):1235-43. PubMed ID: 26769042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of donepezil for the treatment of dementia with Lewy bodies.
    Rojas-Fernandez CH
    Ann Pharmacother; 2001 Feb; 35(2):202-5. PubMed ID: 11215841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
    Vollmar HC; Butzlaff M
    Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of donepezil on the P300 auditory and visual cognitive evoked potentials of patients with Alzheimer's disease.
    Reeves RR; Struve FA; Patrick G; Booker JG; Nave DW
    Am J Geriatr Psychiatry; 1999; 7(4):349-52. PubMed ID: 10521169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing in combination with preventive donepezil treatment for patients with amnestic mild cognitive impairment: an exploratory economic evaluation of personalized medicine.
    Djalalov S; Yong J; Beca J; Black S; Saposnik G; Musa Z; Siminovitch K; Moretti M; Hoch JS
    Mol Diagn Ther; 2012 Dec; 16(6):389-99. PubMed ID: 23188525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear.
    Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 17. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 18. Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
    Blacker D
    N Engl J Med; 2005 Jun; 352(23):2439-41. PubMed ID: 15829528
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates.
    Torjesen I
    BMJ; 2015 Oct; 351():h5739. PubMed ID: 26506953
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
    Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.